Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
0.300
+0.003 (1.04%)
At close: Nov 6, 2024, 4:00 PM
0.302
+0.002 (0.77%)
Pre-market: Nov 7, 2024, 9:17 AM EST
Bionano Genomics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Net Income | -204.1 | -232.49 | -132.6 | -72.44 | -41.11 | -29.82 | Upgrade
|
| Depreciation & Amortization | 13.42 | 13.91 | 9.84 | 3.37 | 1.48 | 1.13 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.37 | - | - | - | - | 0.01 | Upgrade
|
| Asset Writedown & Restructuring Costs | 77.73 | 77.28 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.02 | 0.02 | 0.07 | - | - | - | Upgrade
|
| Stock-Based Compensation | 12.96 | 15.18 | 22.42 | 9.72 | 1.55 | 1.35 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | - | - | 1.81 | 0.55 | Upgrade
|
| Other Operating Activities | -1.35 | 15.69 | 3.4 | -4.93 | 1.39 | 2.22 | Upgrade
|
| Change in Accounts Receivable | 1.36 | -2.3 | -2.25 | -0.49 | 2.09 | -2.37 | Upgrade
|
| Change in Inventory | 2.12 | -4.15 | -23.68 | -15.93 | -4.2 | -3.64 | Upgrade
|
| Change in Accounts Payable | -2.85 | -2 | 1.95 | 6.78 | -1.81 | 1.36 | Upgrade
|
| Change in Other Net Operating Assets | -4.86 | -6.33 | -3.96 | 1.99 | 0.48 | -0.32 | Upgrade
|
| Operating Cash Flow | -105.18 | -125.18 | -124.82 | -71.93 | -38.31 | -29.53 | Upgrade
|
| Capital Expenditures | -0.92 | -1.69 | -3.2 | -1.46 | - | -0.06 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.03 | - | - | - | Upgrade
|
| Cash Acquisitions | - | 0.1 | -30.65 | -49.09 | -2.45 | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -0.1 | - | - | - | Upgrade
|
| Investment in Securities | 55.19 | 25.75 | 116.69 | -226.91 | - | - | Upgrade
|
| Other Investing Activities | - | - | - | -0.61 | - | - | Upgrade
|
| Investing Cash Flow | 54.27 | 24.16 | 82.77 | -278.06 | -2.45 | -0.06 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 2.54 | 24.25 | Upgrade
|
| Short-Term Debt Repaid | - | -9 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.05 | -0.04 | -15.01 | -7.26 | -14.43 | Upgrade
|
| Total Debt Repaid | -70.05 | -9.05 | -0.04 | -15.01 | -7.26 | -14.43 | Upgrade
|
| Net Debt Issued (Repaid) | -52.05 | -9.05 | -0.04 | -15.01 | -4.72 | 9.82 | Upgrade
|
| Issuance of Common Stock | 51.84 | 57.83 | 23.62 | 352.82 | 68.63 | 20.56 | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | -2 | - | Upgrade
|
| Other Financing Activities | 57.69 | 65.04 | -0.58 | -1.7 | - | - | Upgrade
|
| Financing Cash Flow | 57.48 | 113.82 | 23.01 | 336.11 | 61.9 | 30.38 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.01 | 0.07 | -0.04 | - | - | - | Upgrade
|
| Net Cash Flow | 6.58 | 12.86 | -19.08 | -13.88 | 21.14 | 0.79 | Upgrade
|
| Free Cash Flow | -106.1 | -126.87 | -128.02 | -73.39 | -38.31 | -29.59 | Upgrade
|
| Free Cash Flow Margin | -290.07% | -351.29% | -460.46% | -408.14% | -450.59% | -292.12% | Upgrade
|
| Free Cash Flow Per Share | -2.17 | -3.72 | -4.43 | -2.65 | -3.68 | -19.76 | Upgrade
|
| Cash Interest Paid | 11.17 | 1.65 | 0.3 | 1.91 | 1.25 | 1.28 | Upgrade
|
| Levered Free Cash Flow | -55.98 | -97.73 | -61.27 | -38.49 | -16.43 | -17.87 | Upgrade
|
| Unlevered Free Cash Flow | -51.85 | -94.53 | -61.08 | -37.91 | -14.85 | -16.44 | Upgrade
|
| Change in Net Working Capital | 11.91 | 34.78 | 9.05 | 2.33 | -5.27 | 2.69 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.